Ovid Therapeutics Inc share price logo

Ovid Therapeutics Inc Share Price

NASDAQ: OVID

Small Cap

$1.25

(+0.40%)

as on

Ovid Therapeutics Inc Stock Performance

as on September 13, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $1.22
    $1.3
    downward going graph

    2.40%

    Downside

    4.00%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.24
    $1.47
    downward going graph

    80.60%

    Downside

    17.60%

    Upside

    downward going graph

Ovid Therapeutics Inc share price movements today

Previous Close
$1.25
Open
$1.26
Volume
1.1M
Day's Low - High
$1.22 - $1.3
52 Week Low - High
$0.24 - $1.47

Ovid Therapeutics Inc Historical Returns

1 Month Return
+ 46.85 %
3 Month Return
+ 349.68 %
1 Year Return
+ 5.88 %
3 Year Return
-40.57 %
5 Year Return
-77.93 %

Ovid Therapeutics Inc Stock Fundamentals & Key Indicators

Check Ovid Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$88.9M

EPS (TTM)

-0.48

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-2.86

Industry PE ratio

0

P/B Ratio

0

PEG Ratio

0

EBITDA

-41.2M

Revenue (TTM)

6.7M

Profit Margin

0.00%

Return On Equity TTM

174034400.00%

Ovid Therapeutics Inc Stock Valuation

Track how Ovid Therapeutics Inc P/E has moved over time to understand its valuation trends.

Ovid Therapeutics Inc in the last 5 years

  • Overview

  • Trends

Lowest (1.69x)

December 31, 2021

Industry (0.00x)

September 13, 2025

Today (-2.86x)

September 13, 2025

Highest (2.35x)

June 30, 2021

LowHigh

Today’s Price to Earnings Ratio: -2.86x

Ovid Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Ovid Therapeutics Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$88.9M-77.93%-2.860.00%
BUY$61.1B280.5%-505.15-12.96%
NA$37.7BNANA-3.89%
BUY$101.2B54.04%28.0831.86%
BUY$59.4B2.03%14.1131.37%

Stock Returns calculator for Ovid Therapeutics Inc Stock including INR - Dollar returns

The Ovid Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Ovid Therapeutics Inc investment value today

Current value as on today

₹1,10,181

Returns

₹10,181

(+10.18%)

Returns from Ovid Therapeutics Inc Stock

₹5,042 (+5.04%)

Dollar Returns*

₹5,139 (+5.14%)

Analyst Recommendation on Ovid Therapeutics Inc Stock

Based on 16 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 16 analysts, 87.5% of analysts recommend a 'BUY' rating for Ovid Therapeutics Inc. Average target price of $3.4

Ovid Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Ovid Therapeutics Inc.

What analysts predicted

63.24%UPSIDE

Target Price

$3.4

Current Price

$1.25

Analyzed by

16 Analysts

Target

$3.40

Ovid Therapeutics Inc target price $3.4, a slight upside of 63.24% compared to current price of $1.25. According to 16 analysts rating.

Ovid Therapeutics Inc Stock's Interest Amongst Investors

Search interest for Ovid Therapeutics Inc Stock has decreased by -11% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-11% versus previous 30 day period

Ovid Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
0
0
0
0
0
0
0
0
0
6
Gross Profit
0
75
0
0
0
0
0
0
0
6
Operating Income
-14
-14
-12
-18
-17
-20
-13
-10
-12
-5
EBITDA
-14
-14
-11
-14
-17
-20
-13
-10
-12
-5
Interest Expense
1,536
-
-
1,536
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-13
-12
-11
-15
-11
8
-14
-9
-10
-4
Income Tax Expense
-1,536
0
0
0
0
-
-
-
-
-
Net Income
-13
-12
-11
-15
-11
8
-14
-9
-10
-4
Net Profit Margin
-20236.36%
-16544.00%
-10325.59%
-10823.53%
-7901.35%
5042.01%
-8095.95%
-12175.00%
-7873.08%
-74.68%

Ovid Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
-
-
-
-
-
12
208
1
0
0
Gross Profit
0
0
0
0
0
12
208
1
0
0
Operating Income
-13
-22
-65
-52
-61
-81
124
-55
-59
-61
EBITDA
-13
-22
-64
-52
-61
-81
124
-54
-57
-57
Interest Expense
-
-
-
-
-
-
0
2
-
-
Depreciation
-
-
0
0
0
0
0
1
1
0
Income Before Tax
-13
-22
-64
-51
-60
-81
124
-54
-52
-26
Income Tax Expense
-
0
0
0
-1
0
1
-2
0
-
Net Income
-13
-22
-64
-51
-59
-80
122
-51
-52
-26
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
-639.83%
58.95%
-3420.95%
-13362.18%
-4670.14%

Ovid Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-12
-11
-15
-11
8
-14
-9
-10
-4
Operating Cash Flow
-11
-10
-11
-16
-14
-15
-10
-10
-4
Investing Cash Flow
20
-4
-48
20
12
0
21
5
12
Financing Cash Flow
0
0
30
0
0
0
-
0
-
Change in Cash
8
-14
-30
3
-1
-14
11
-5
7

Ovid Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-22
-64
-51
-60
-81
122
-54
-52
-26
Operating Cash Flow
-17
-31
-45
-51
-51
118
-55
-45
-55
Investing Cash Flow
0
0
-5
-30
34
-1
-87
-2
54
Financing Cash Flow
0
66
0
86
47
0
0
30
0
Change in Cash
-18
35
-50
5
30
117
-142
-17
0

Global Institutional Holdings in Ovid Therapeutics Inc

Funds
Holdings
Takeda Pharmaceutical Co Ltd
10.59%
Rubric Capital Management LP
7.48%
BlackRock Inc
5.43%
Bvf Inc
5.42%
Vanguard Group Inc
4.37%

Insights on Ovid Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 3 quarters, 76.0K → 6.27M (in $), with an average increase of 69.7% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, OVID stock has moved up by 347.9%

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -10.23M → -4.68M (in $), with an average increase of 118.5% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.7% return, outperforming this stock by 70.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 123.5% return, outperforming this stock by 166.2%

About Ovid Therapeutics Inc

ovid therapeutics is a biopharmaceutical company focused exclusively on developing impactful medicines for patients and families living with rare neurological disorders. ovid’s drug candidate, ov101, is currently in development for the treatment of symptoms of angelman syndrome and fragile x syndrome. ovid is also developing ov935 in collaboration with takeda pharmaceutical company limited for the treatment of rare epileptic encephalopathies. ovid has initiated the phase 2 stars trial of ov101 in adults with angelman syndrome and a phase 1 trial in adolescents with angelman and fragile x syndrome to identify doses suitable for younger patients. review our community guidelines: http://www.ovidrx.com/community-guidelines/
OrganisationOvid Therapeutics Inc
Headquarters441 Ninth Avenue, New York, NY, United States, 10001
IndustryHealth Technology
CEODr. Jeremy Max Levin Ba Zoology, Dphil, M.D., Mb Bchir, Ph.D.
E-voting on sharesClick here to vote

Key Management of Ovid Therapeutics Inc

Name

Title

Dr. Jeremy Max Levin Ba Zoology, Dphil, M.D., Mb Bchir, Ph.D.

CEO & Chairman

Ms. Margaret Alexander

President & COO

Dr. Dirk Haasner

Senior Vice President of Global Manufacturing & CMC QA

Dr. Manal Morsy M.B.A., M.D., PH.D.

Chief Regulatory Officer

Dr. Toshiya Nishi D.V.M.

Head of Epilepsy Research

Ms. Victoria Fort

Senior Vice President of Corporate Affairs & Corporate Strategy

Mr. Jeffrey A. Rona

Chief Business and Financial Officer

Dr. Zhong Zhong Ph.D.

Chief Scientific Officer

Dr. Amanda Banks M.D.

Chief Development Officer

Dr. Julia Tsai Ph.D.

Senior Vice President of Clinical Development

FAQs

What is Ovid Therapeutics Inc share price today?

Ovid Therapeutics Inc share price today is $1.25 as on at the close of the market. Ovid Therapeutics Inc share today touched a day high of $1.3 and a low of $1.22.

What is the 52 week high and 52 week low for Ovid Therapeutics Inc share?

Ovid Therapeutics Inc share touched a 52 week high of $1.47 on and a 52 week low of $0.24 on . Ovid Therapeutics Inc stock price today i.e. is closed at $1.25,which is 14.97% down from its 52 week high and 415.46% up from its 52 week low.

What is Ovid Therapeutics Inc's market capitalisation today?

Ovid Therapeutics Inc market capitalisation is $0.00T as on .

How to invest in Ovid Therapeutics Inc Stock (OVID) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Ovid Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Ovid Therapeutics Inc Shares that will get you 1.2000 shares as per Ovid Therapeutics Inc share price of $1.25 per share as on September 13, 2025 at 1:29 am IST.

What is the minimum amount required to buy Ovid Therapeutics Inc Stock (OVID) from India?

Indian investors can start investing in Ovid Therapeutics Inc (OVID) shares with as little as ₹88.27 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹882.70 in Ovid Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Ovid Therapeutics Inc share’s latest price of $1.25 as on September 13, 2025 at 1:29 am IST, you will get 8.0000 shares of Ovid Therapeutics Inc. Learn more about fractional shares .

What are the returns that Ovid Therapeutics Inc has given to Indian investors in the last 5 years?

Ovid Therapeutics Inc stock has given -77.93% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?